Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Wexford Capital Cuts Its Diamondback Energy Position

Wexford Capital, managed by Charles Davidson, reduced its exposure in Diamondback Energy Inc (NASDAQ:FANG) to around 10.74 million shares, from some 11.78 million, disclosed in its latest 13F. Following the decrease, the holding amasses 22.8% of Diamondback’s outstanding common stock.

Diamondback Energy

In the first half of November, Diamondback Energy conducted a Secondary Public Offering. The company offered for purchase 2.0 million shares held by Gulfport Energy Corporation (NASDAQ:GPOR). The price for securities for the underwritten offering has been set at $53.46 per share. All the proceeds from the sale of shares will go to Gulfport, Diamondback said. At the same time, the underwritters will be able to buy at most 300,000 additional shares from Gufport.

Diamondback posted a net income of $14.6 million ($0.33 per diluted share) for the third quarter of 2013, almost flat over the quarter. “Our operations team continues to improve performance by reducing cycle times and costs. We have achieved four consecutive quarters of double digit declines in lease operating expense reduction, which are down over 50% from this same period last year,” said Travis Stice, Chief Executive Officer of Diamondback.

For next, year, Diamondback expects its EBITDA to amount to at least $291 million (taking into account the lowest oil price of $80 per barrel). The total production of the company is forecasted to be between 15 and 16 Barrels of oil equivalent per day. The guidance shows the company will double its production over the year, in 2014.

Even though, Wexford holds a significant stake in the company, some other “hedgies” have also been bullish on the company. Donald Chiboucis Columbus Circle Investors holds almost 1.1 million shares, and Ken Griffin‘s Citadel Investment Group owns 658,800 shares, according to our database.

Disclosure: none

Recommended Reading:

Kyle Bass’ Hayman Advisors Discloses Position in Post-IPO NMI Holdings

Nelson Peltz, Trian Partners Boost Stake in Ingersoll-Rand PLC

Israel Englander, Millennium Management Love PPL Corporation & Baker Hughes Among Others

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!